nadunolimab
i-mab,cantargia
['nadunolimab', 'imab ', 'cantargia']
cantargia s antibody nadunolimab inhibits il-1 / -induced cxcr1/2 ligand expression and reduces serum levels of cxcl1 and cxcl5 in nsclc and pdac patients. 